-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Downgrades Soleno Therapeutics to Hold, Lowers Price Target to $53

Benzinga·04/07/2026 13:54:01
Listen to the news
TD Cowen analyst Tyler Van Buren downgrades Soleno Therapeutics (NASDAQ:SLNO) from Buy to Hold and lowers the price target from $85 to $53.